A slower, more gradual dose escalation as is standard practice with GLP-1-based therapies may help mitigate the intensity and duration of tiredness
The dose schedule should always be maintained at seven-day intervals, give or take 24 hours
144,145,146,147 Triple agonist Triple agonists go even further
Whether a health plan with a traditional carrier network, or as an overlay to an existing Utilization Review/Case Management program, or if the desire is to have a new stand-alone GLP-1 offering that delivers successful clinical and financial outcomes
Complementing its insulinotropic effects, GLP-1 also suppresses the release of glucagon, slows gastric emptying and intestinal motility, and induces feelings of satiety 5